top of page

Pharmaceuticals
Ensuring Compliance and Operational Continuity:
Cyber Recovery in Pharma
Pharmaceutical manufacturing faces unique cyber risks where downtime disrupts GMP processes, regulatory compliance, and ultimately patient safety. Recent incidents, such as Eisai’s 2023 ransomware attack, illustrate the operational impact. At the same time, FDA data-integrity guidance requires that backups be validated, tamper-evident, and fully restorable with audit trails.
The priority is clear: organizations must move beyond defense alone to ensure instant, verified restoration of critical OT and GxP systems, minimizing disruption, damage, and risk.
bottom of page
